The Highwire with Del Bigtree - NEW STUDIES SHOW SERIOUS RISKS OF GENDER TRANSITION

Episode Date: May 19, 2024

New studies are highlighting the potential serious permanent harms from using puberty blockers and cross sex hormones for those suffering from gender dysphoria. The push to put minors on a fast course to gender transition appears to be coming to an end as the public, legislative, and medical bodies are all reversing course.Become a supporter of this podcast: https://www.spreaker.com/podcast/the-highwire-with-del-bigtree--3620606/support.

In the transgender conversation, this is where the high wire really jumped in. The idea of giving minors medications that have no long-term track record of safety when it comes to what they're being used for, often against parents' wishes and behind parents' backs. This is a conversation that since about this past month, the CAST report came out in the UK. And what did that do? That said there needs to be an extremely cautious approach in giving kids these drugs because of the lack of the scientific literature. and there's been a huge back off after that report. And it continues, this is the hill.

This is their op-ed in the hill, and they're starting to sound like this. The reckoning over puberty blockers has arrived. And you go into this article, and it says parents who have consented to these drugs for their children love their kids dearly, but they've consented under entirely false pretenses. The doctors who've advised them to say that puberty blockers are known to improve mental health, that they are even life-saving, and that they're fully reversible and just give kids time to think. None of this is true. So this is what they're, this is, I mean, these are strong words here.

And so the puberty blockers, the doctors are saying this on the pretense, well, we just give kids time. They're, they're wrestling with this, this, these things right now. These puberty blockers will give them time to think about what direction they want to go. Well, the science is saying different. Here's a study and it's looking at, are these reversible? And so they, this is called puberty blockers. And meanwhile, let's look this up. Puberty blocker in the aging impact of testicular.

cell states and function. And it says in there, herein we report the largest clinically annotated juvenile testicular biorepository with all children with gender dysphoria on chronic puberty blocker treatment, highlighting shifts in pediatric patient demography in the U.S. At the tissue level, we report mild to severe sex gland atrophy, that's shrinkage, in puberty blocker treatment children. That also goes on to say this combined with the noted gland atrophy and abnormalities from the histology data raises a potential. concern regarding the complete reversibility and reproductive fitness of SSC, that's spermatoganyl stem cells. What those are is basically the foundation of male fertility, sperm

generation, and they're saying, there's a big question. They're looking at the tissues, and they're saying, we're seeing these big changes, and we don't think this may be reversible, and this is one of the largest databases we're looking at here. And so those are the puberty blockers. And when we talk about this conversation, you have kind of two aspects of this. You have the puberty blockers to stop that natural puberty that's happening in an individual. And then you have the gender affirming hormones that are the second phase that direct them towards the gender they prefer. So, you know, when they say, just start with these puberty blockers. They'll give them time to think. That is a gateway. And it's almost a direct 100% gateway. In this study here, they're looking at

the trajectory of people that have started puberty blockers. Do they go, do they stop them? Do they go on? Do they have a second thought about this? No, they said of the 707 eligible V-MAC participants using G-R-I'm sorry, GNR-H-A, 93% subsequently started gender-affirming hormones. So that GNR-HA, those are gnatotropin-releasing hormone agonists, so those are puberty blockers, basically. And so once you go to that second phase of the gender-affirming hormones, there's a lot of studies that show the dangers of this.

So here's one of them, cardiac risks. This is the study that's showing there's a higher risk of strokes and heart attacks in transgender individuals receiving that type of hormone therapy than against the general population. Another one is breast cancer risks. This study shows a higher risk of breast cancer and trans women receiving these type of hormones. So it's no surprise that legislation has been moving in a certain direction, especially the United States here. This is South Carolina.

They're now joining 24 other states in banning sex change. treatments on minors. So there's the legislative approach just going after this. Whether you think it's right or wrong, that seems to be the trend. And even this is interesting, too, the California Justice Department tells the court it can't, cannot force schools to transition kids behind their parents' backs. This is kind of a nuanced story, but it's interesting because the Attorney General Rob Bonta in California is expected to run for governor has been publicly saying, we will fight, we will use legal methods if schools try to block this, if schools try to block this transition. But when Preston court, the representatives for the AG's office there in California said,

we actually don't have the legal right to do this. So that's an interesting space that that whole conversation is. California is one of the standout states that is approving this and it's a sanctuary state, they call it, for minors that are seeking this type of therapies. But there's also a trend change in the conversation of the terminology being used, and that's the transgender ideology in hospitals. So this is the headline out of the UK, chest feeding to be banned in NHS crackdown. So this new approach that NHS is taking is they're going to ban transgender women from being treated on single-sex female hospital wards. So they're going to try to protect female privacy and protection. And they also are allowing people that are. I mean, this just, again, this is like

this sort of no doubt. I mean, beyond just like you're sort of single-sex hospital wards or floors, these are doctors that specialize in female care, gynecologists and things like that. What do they know about a man who's seeing himself as a woman, like on their floor? I don't, I never studied, you know, I'm always worked, yeah, the anatomy of men. It's a great way to put. I realize some of you are watched with your homeschool class and maybe because this conversation is going to continue with my next guest. So it may be time to decide if you want to have this conversation with your kids watching. But I mean, think about it. We have doctors that are designed to take care of men for specific reasons and women for specific reasons.

And now you're putting, I'm sorry, physically attributed men whose minds make them believe that they're women. But what does that do for the doctors in those flog? I can't do anything for you. I mean, I just, this, obviously I'm glad that the UK is coming around and recognizing the type of madness that we're involved in here. It's, it's really insane. And what's interesting is, as the UK is making this turn, just last year, the CDC here in the U.S. is going full speed. It looks like kind of in the other direction where they're actually giving guidance to chest feeding. This was the headline for that one.

CDC gives guidance for trans people chest feeding kids accused of failing to consider possible health risks. But then Mississippi is also. also from the legislative aspect, they're going the way of the NHS here, and they have legislation that signed into law defining sexes and protecting single-sex spaces for women. So we're talking about single-sex spaces like restrooms, public housing, changing facilities. So they're actually codifying biological sex in the law, man, and woman. So this conversation over this last month has moved so fast and in one direction after that cast report that it really has a lot of people's head spinning and we're trying to keep up with this, but this is a narrative that at one point,

a lot of people were wondering, why are we transitioning with these drugs that aren't really tested for long-term use and safety in this context? It seems to be a little more rationality coming to this conversation saying, hold on, let's look at this a little deeper. And, you know, NHS and the Cass report really has seemed to lead this point. Yeah, it's really interesting. and it has. I mean, this whole thing is like sort of cycled and peaked and is now going the other direction. All feels like almost within the last year, I feel like we haven't been reporting on it that long and just watching. And maybe it's because so many people like us are reporting on.